AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Biodesix at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Biodesix brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 544. Its session covers monitoring residual disease and emerging treatment resistance through blood testing. The company offers diagnostic tests supporting lung cancer decisions, plus testing services for biopharma and research organizations.

OrganizationAMP 2026 Attendance
Biodesix
Louisville, CO
Diagnostics
Diagnostic tests supporting clinical decisions in lung cancer, plus testing capabilities and services for biopharma and research organizations.
Booth
Exhibiting at Booth 544
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
4:00pm–4:50pm
Listening for the Whisper - Monitoring Residual Disease and Emerging Resistance in the Blood
Droplet digital PCR, spatial and sequencing assays used together to monitor cancer treatment response in blood and tissue.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Biodesix

Tell us what you sell and we’ll find the people at Biodesix most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction